Literature DB >> 28933233

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis.

Roberta Lanzillo1, Gilda Cennamo2, Chiara Criscuolo1, Antonio Carotenuto1, Nunzio Velotti2, Federica Sparnelli2, Alessandra Cianflone1, Marcello Moccia1, Vincenzo Brescia Morra1.   

Abstract

BACKGROUND: Optical coherence tomography (OCT) angiography is a new method to assess the density of the vascular networks. Vascular abnormalities are considered involved in multiple sclerosis (MS) pathology.
OBJECTIVE: To assess the presence of vascular abnormalities in MS and to evaluate their correlation to disease features.
METHODS: A total of 50 MS patients with and without history of optic neuritis (ON) and 46 healthy subjects were included. All underwent spectral domain (SD)-OCT and OCT angiography. Clinical history, Expanded Disability Status Scale (EDSS), Multiple Sclerosis Severity Score (MSSS) and disease duration were collected.
RESULTS: Angio-OCT showed a vessel density reduction in eyes of MS patients when compared to controls. A statistically significant reduction in all SD-OCT and OCT angiography parameters was noticed both in eyes with and without ON when compared with control eyes. We found an inverse correlation between SD-OCT parameters and MSSS ( p = 0.003) and between vessel density parameters and EDSS ( p = 0.007).
CONCLUSION: We report a vessel density reduction in retina of MS patients. We highlight the clinical correlation between vessel density and EDSS, suggesting that angio-OCT could be a good marker of disease and of disability in MS.

Entities:  

Keywords:  Retinal vascular abnormalities; multiple sclerosis; optical coherence tomography angiography

Mesh:

Year:  2017        PMID: 28933233     DOI: 10.1177/1352458517729463

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  29 in total

Review 1.  Optical coherence tomography in multiple sclerosis.

Authors:  Josefine Britze; Jette Lautrup Frederiksen
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

Review 2.  Optical coherence tomography angiography-derived flow density: a review of the influencing factors.

Authors:  Viktoria C Brücher; Jens J Storp; Nicole Eter; Maged Alnawaiseh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-09       Impact factor: 3.117

3.  Visual Function and Disability Are Associated with Increased Retinal Volumetric Vessel Density in Patients with Multiple Sclerosis.

Authors:  Hong Jiang; Giovana Rosa Gameiro; Yi Liu; Ying Lin; Jeffrey Hernandez; Yuqing Deng; Giovanni Gregori; Silvia Delgado; Jianhua Wang
Journal:  Am J Ophthalmol       Date:  2020-01-08       Impact factor: 5.258

4.  The vessel density of the superficial retinal capillary plexus as a new biomarker in cerebral small vessel disease: an optical coherence tomography angiography study.

Authors:  Xiaojing Wang; Qiang Wei; Xingqi Wu; Shanshan Cao; Chen Chen; Jun Zhang; Yibing Yan; Zhi Geng; Yanghua Tian; Kai Wang
Journal:  Neurol Sci       Date:  2021-01-11       Impact factor: 3.307

Review 5.  What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Authors:  Ziya Ayhan; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

6.  Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures.

Authors:  Olwen C Murphy; Ohemaa Kwakyi; Mustafa Iftikhar; Sidra Zafar; Jeffrey Lambe; Nicole Pellegrini; Elias S Sotirchos; Natalia Gonzalez-Caldito; Esther Ogbuokiri; Angeliki Filippatou; Hunter Risher; Norah Cowley; Sydney Feldman; Nicholas Fioravante; Elliot M Frohman; Teresa C Frohman; Laura J Balcer; Jerry L Prince; Roomasa Channa; Peter A Calabresi; Shiv Saidha
Journal:  Mult Scler       Date:  2019-05-16       Impact factor: 6.312

7.  Effect of Vascular Comorbidity on Visual and Disability Outcomes in a Secondary Progressive Multiple Sclerosis Clinical Trial Cohort.

Authors:  Kathleen Shangraw; Charles F Murchison; Elizabeth Silbermann; Rebecca I Spain
Journal:  Int J MS Care       Date:  2022-04-18

8.  OCT Variability Prevents Their Use as Robust Biomarkers in Multiple Sclerosis.

Authors:  Marta Para-Prieto; Raul Martin; Sara Crespo; Laura Mena-Garcia; Andres Valisena; Lisandro Cordero; Gloria Gonzalez Fernandez; Juan F Arenillas; Nieves Tellez; Jose Carlos Pastor
Journal:  Clin Ophthalmol       Date:  2021-05-14

9.  Relationship between optical coherence tomography angiography and visual evoked potential in patients with multiple sclerosis.

Authors:  Sedat Ava; Yusuf Tamam; Leyla Hazar; Mine Karahan; Seyfettin Erdem; Mehmet Emin Dursun; Ugur Keklikçi
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

10.  Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.

Authors:  Małgorzata Rogaczewska; Sławomir Michalak; Marcin Stopa
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.